查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1747680

全球人造骨市場

Artificial Bones
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 177 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2030年全球人造骨市場規模將達24億美元

全球人造骨市場規模預計在2024年為18億美元，預計到2030年將達到24億美元，2024年至2030年的複合年成長率為5.7%。陶瓷材料是本報告分析的細分市場之一，預計其複合年成長率為4.5%，到分析期結束時市場規模將達到8.357億美元。複合材料細分市場在分析期間的複合年成長率預計為7.2%。

美國市場規模估計為 4.61 億美元，中國市場預計複合年成長率為 5.6%

預計到2024年，美國骨替代市場規模將達到4.61億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到3.931億美元，在2024-2030年的分析期間內，複合年成長率為5.6%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為4.9%和5.1%。在歐洲，預計德國市場的複合年成長率為4.7%。

全球人造骨市場－主要趨勢與促進因素摘要

為什麼人工骨骼對於整形外科、創傷和重組外科的進步至關重要？

人工骨是合成或生物工程製成的替代物，用於替換、修復和強化受損或缺失的骨組織。它們在整形外科、創傷照護、牙齒重組、腫瘤相關骨缺損治療等領域日益重要。隨著人口老化、高強度衝擊損傷以及骨質疏鬆症和骨關節炎等慢性疾病導致全球骨相關疾病發病率上升，對可靠且生物相容性的骨植體的需求持續飆升。

在創傷和整形外科手術中，骨替代物可作為支架，促進骨再生、填補結構空隙並恢復動態完整性。這些替代物通常用於天然骨移植不足或不切實際的情況，例如脊椎融合手術、長骨骨折修復、關節重組以及複雜的翻修手術。與自體和同種異體骨移植相比，骨替代物可降低供體部位的發生率，消除疾病傳播的風險，並且可擴展使用，因此極具價值，尤其是在高容量的醫療保健系統和急診外科環境中。

人工骨用於顎顏面手術、顱骨缺損修復和人工植牙等重組應用，這些應用著重精準度、骨整合和美觀。 3D列印和客製化形狀的骨植體正日益廣泛應用，以改善解剖貼合度、縮短手術時間並提升術後功能。隨著外科技術的進步和患者期望值的提高，人工骨解決方案正從被動填充材發展成為現代肌肉骨骼護理中主動的生物整合組件。

材料創新、生物整合和積層製造如何改變產品性能？

材料科學是人工骨骼發展的核心。傳統的磷酸鈣基材料，例如羥基磷灰石和磷酸三鈣，因其生物相容性和骨傳導性而備受推崇。然而，生物活性玻璃、聚合物-陶瓷複合材料和奈米結構支架等新型複合材料則具有更高的機械強度、可控制的吸收速率和卓越的生物相互作用。這些創新使人工骨更適用於承重和非承重應用。

生物整合是關鍵的進展領域，工程骨產品融合了生長因子、幹細胞和表面改性，以促進骨誘導和血管化。採用重組骨生成激素(rhBMP) 和富血小板血漿 (PRP) 塗層的產品促進了骨再生，尤其是在複雜或無法癒合的缺損中。表面紋理和圖形化也透過改善細胞黏附性和促進與宿主組織的整合，使植入具有更強的生理響應性。

積層製造（3D列印）正在徹底改變患者客製化人工骨植入物的生產方式。利用CT和MRI影像數據，外科醫師和工程師可以設計出符合個體骨骼結構的解剖學精確模型，最大限度地減少術中調整，並最大限度地提高動態力學相容性。這些客製化植入由鈦、PEEK或生物陶瓷材料製成，目前已用於顱腦、脊椎和整形外科腫瘤手術。隨著製造成本的降低和監管途徑的簡化，3D列印骨替代物有望成為個人化整形外科治療的標準。

哪些臨床領域和地理市場正在推動人工骨解決方案的採用？

整形外科仍然是骨假體最大的臨床應用領域，尤其是在脊椎融合手術、骨折修復和關節重新置換置換術方面。由於全球人口老化和骨質疏鬆症相關骨折發生率的上升，醫療保健系統正在優先考慮微創解決方案，以減少住院時間並促進更快康復。在脊椎和創傷外科手術中，骨假體通常與金屬固定裝置一起使用，以提高癒合率並穩定結構完整性。

牙科和顎顏面外科也是一個高成長領域，其驅動力源於牙周治療、植入固定以及拔牙後齒槽窩保存對移植骨替代物的需求。由於合成骨填充劑無菌、易於操作且吸收性穩定，牙科專業人員擴大採用合成骨填充材。在腫瘤學領域，它們用於保肢手術和腫瘤切除後的重組手術，尤其是在傳統骨移植選擇有限的兒童和老年患者中。

從地區來看，北美和歐洲憑藉其先進的外科基礎設施、完善的報銷制度以及生物和3D列印移植技術的早期應用，引領市場。亞太地區正經歷快速成長，這得益於醫療服務可及性的擴大、醫療旅遊的興起以及中國、印度、日本和韓國整形外科手術數量的不斷增加。拉丁美洲和中東是新興市場，在這些地區，官民合作關係和整形外科推廣計畫正在推動創傷和重組醫學領域採用經濟高效的合成移植替代方案。

不斷發展的法規、臨床證據和成本績效指標如何影響競爭策略？

美國食品藥物管理局 (FDA) 和歐洲藥品管理局 (EMA) 等監管機構正在不斷更新指南，以確保工程骨產品的安全性、有效性和品管。循證核准的轉變正在鼓勵製造商投資長期臨床試驗和上市後監測，以檢驗在不同患者群體中的效果。關於生物增強型移植物和個人化植入的新興監管法規也在簡化創新流程，同時確保臨床醫生和患者對新解決方案的信心。

最佳化性價比仍然是骨假體應用的關鍵決定因素。醫院和採購機構會根據操作的便利性、整合速度、手術效果以及與自體移植和同種異體移植的比較價格來評估骨假體。提供模組化移植系統、臨床醫生培訓和療效追蹤的製造商已獲得競爭優勢，尤其是在價格敏感的醫療保健環境中。基於價值的醫療保健模式正在提升那些能夠降低再手術率、加快康復速度並降低總護理成本的產品的重要性。

器械製造商、生物技術公司和研究機構之間的策略夥伴關係正在加速下一代人造骨骼的開發。這些聯盟正在推動智慧骨植入的創新，這些植入物融合了生物感測器、藥物傳輸功能和再生塗層。在日益激烈的競爭中，品牌建立、外科醫生忠誠度計畫和差異化的臨床支援服務正成為成熟地區和新興地區市場定位的核心。

哪些因素推動了人造骨市場的成長？

由於人口老化、整形外科技術創新以及對安全、可擴展的自體移植替代品的需求，人工骨市場正在迅速擴張。隨著全球對骨缺損、創傷和重組的需求日益成長，人工骨為各種外科手術提供了可靠、多功能的解決方案。其能夠減少併發症、消除供體部位併發症並加快恢復時間，越來越符合現代外科手術和經濟效益的優先考慮。

材料、生物整合和病患客製化的產品創新正在重塑競爭動態，並拓展臨床適應症。監管環境、外科醫生的認可度以及研發開發平臺的投資正在強化商業化格局。隨著醫療保健系統尋求經濟高效、以結果為導向的整形外科解決方案，人工骨骼正逐漸成為下一代肌肉骨骼療法的基石。

展望未來，市場發展軌跡將取決於人工骨技術與個人化醫療、再生療法和數位化手術工作流程的有效組合。隨著生物智慧和功能自適應植入的需求日益成長，人工骨能否發展成為智慧支架，不僅能夠取代人體骨骼結構，還能主動再生和修復？

部分

材料（陶瓷、複合材料、聚合物、羥基磷灰石、其他材料）、應用（脊椎融合、牙科、顱顎顏面、關節重組、創傷/四肢）、最終用戶（醫院、專科診所、研究/學術機構）

受訪公司範例（總合37家）

  • AlloSource
  • Baxter International Inc.
  • Biogennix
  • Biomatlante
  • Bone Support AB
  • Cowellmedi Co., Ltd.
  • Curasan AG
  • DePuy Synthes（Johnson & Johnson）
  • DSM Biomedical
  • Epibone
  • Geistlich Pharma AG
  • Graftys SA
  • Kuros Biosciences AG
  • LifeNet Health
  • Mathys Ltd Bettlach
  • Maxigen Biotech Inc.
  • Medtronic plc
  • NovaBone Products, LLC
  • NuVasive, Inc.
  • Orthofix Medical Inc.

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口（成品和原始OEM）來預測其競爭地位的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括人為提高銷貨成本、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

全球產業分析師密切關注來自全球頂尖首席經濟學家（14,949位）、智庫（62家）以及貿易和產業協會（171家）的專家的意見，以評估其對生態系統的影響並應對新的市場現實。我們追蹤了來自每個主要國家的專家和經濟學家對關稅及其對本國影響的看法。

全球產業分析師預計，這場動盪將在未來2-3個月內逐漸平息，新的世界秩序將更加清晰地建立。全球產業分析師正在即時追蹤這些事態發展。

2025年4月：談判階段

在4月的報告中，我們將探討關稅對全球整體市場的影響，並提供區域市場調整。我們的預測是基於歷史數據和不斷變化的市場影響因素。

2025年7月：最終關稅調整

在各國宣布最終重置後，客戶將在 7 月收到免費更新，最終更新將包含明確的關稅影響分析。

相互和雙邊貿易及關稅影響分析：

美國<>中國<>墨西哥<>加拿大<>歐盟<>日本<>印度<>其他176個國家

領先的產業經濟學家：全球產業分析師知識庫追蹤了 14,949 位經濟學家，其中包括來自民族國家、智庫、貿易和產業協會、大型企業以及各領域專家的最具影響力的首席經濟學家，他們共用了這場前所未有的全球經濟狀況模式轉移的影響。我們超過 16,491 份報告大多遵循基於里程碑的兩階段發布計劃。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP34623

Global Artificial Bones Market to Reach US$2.4 Billion by 2030

The global market for Artificial Bones estimated at US$1.8 Billion in the year 2024, is expected to reach US$2.4 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2024-2030. Ceramics Material, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$835.7 Million by the end of the analysis period. Growth in the Composite Material segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$461.0 Million While China is Forecast to Grow at 5.6% CAGR

The Artificial Bones market in the U.S. is estimated at US$461.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$393.1 Million by the year 2030 trailing a CAGR of 5.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.9% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global Artificial Bones Market - Key Trends & Drivers Summarized

Why Are Artificial Bones Becoming Integral to Orthopedic, Trauma, and Reconstructive Surgical Advancements?

Artificial bones are synthetic or biologically engineered substitutes designed to replace, repair, or augment damaged or missing bone tissue. They are increasingly vital across orthopedic surgery, trauma care, dental reconstruction, and oncology-related bone defect treatments. As the global incidence of bone-related disorders rises-driven by aging populations, high-impact injuries, and chronic conditions such as osteoporosis and osteoarthritis-demand for reliable, biocompatible bone substitutes continues to surge.

In trauma and orthopedic procedures, artificial bones serve as scaffolds to promote bone regeneration, fill structural voids, and restore biomechanical integrity. These substitutes are often used in spinal fusion, long bone fracture repair, joint reconstruction, and complex revision surgeries where natural bone grafts may be insufficient or impractical. Compared to autografts or allografts, artificial bones reduce donor site morbidity, eliminate disease transmission risk, and offer scalable availability-making them particularly valuable in high-volume healthcare systems and emergency surgical environments.

In reconstructive applications, artificial bones are employed in maxillofacial surgery, cranial defect repairs, and dental implants, where precision, osseointegration, and aesthetic outcomes are paramount. 3D-printed and custom-shaped bone substitutes are increasingly being used to enhance anatomical fit, reduce surgical time, and improve post-operative functionality. As surgical techniques advance and patient expectations rise, artificial bone solutions are evolving from passive fillers to active bio-integrative components of modern musculoskeletal care.

How Are Material Innovations, Biologic Integration, and Additive Manufacturing Transforming Product Capabilities?

Material science is at the core of artificial bone evolution. Traditional calcium phosphate-based materials-such as hydroxyapatite and tricalcium phosphate-are valued for their biocompatibility and osteoconductivity. However, newer composite materials, including bioactive glass, polymer-ceramic hybrids, and nanostructured scaffolds, are offering enhanced mechanical strength, controlled resorption rates, and superior biological interaction. These innovations are making artificial bones more adaptable across load-bearing and non-load-bearing applications.

Biologic integration is a key area of advancement, with artificial bone products now incorporating growth factors, stem cells, and surface modifications to enhance osteoinduction and vascularization. Products featuring recombinant bone morphogenetic proteins (rhBMPs) or platelet-rich plasma (PRP) coatings are accelerating bone regeneration, particularly in complex or non-healing defects. Surface texturing and nano-patterning are also improving cell adhesion and promoting faster host tissue integration, making the implants more physiologically responsive.

Additive manufacturing (3D printing) is revolutionizing the production of patient-specific artificial bone implants. Using CT or MRI imaging data, surgeons and engineers can design anatomically precise models that conform to individual bone structures, minimizing intraoperative adjustments and maximizing biomechanical compatibility. These customized implants-manufactured from titanium, PEEK, or bioceramic materials-are being adopted in cranial, spinal, and orthopedic oncology surgeries. As production costs decrease and regulatory pathways streamline, 3D-printed bone substitutes are expected to become standard practice in personalized orthopedic care.

Which Clinical Segments and Regional Markets Are Driving Adoption of Artificial Bone Solutions?

Orthopedic surgery remains the largest clinical segment for artificial bones, particularly in spinal fusion, fracture repair, and joint revision procedures. With an aging global population and rising rates of osteoporosis-related fractures, healthcare systems are prioritizing minimally invasive solutions that reduce hospital stay and promote faster recovery. In spine and trauma surgery, artificial bones are commonly used alongside metal fixation devices to enhance fusion rates and stabilize structural integrity.

Dental and maxillofacial surgery is another high-growth segment, driven by demand for bone graft substitutes in periodontal treatment, implant anchorage, and post-extraction socket preservation. Dental professionals are increasingly adopting synthetic bone fillers due to their sterility, ease of handling, and consistent resorption profiles. In oncology, artificial bones are used in limb-sparing procedures and post-tumor resection reconstructions, particularly for pediatric and geriatric patients where traditional graft options may be limited.

Regionally, North America and Europe lead the market due to advanced surgical infrastructure, strong reimbursement frameworks, and early adoption of biologic and 3D-printed graft technologies. Asia-Pacific is experiencing rapid growth, supported by expanding healthcare access, medical tourism, and a rising volume of orthopedic procedures in China, India, Japan, and South Korea. Latin America and the Middle East are emerging markets where public-private partnerships and orthopedic outreach programs are driving the adoption of cost-effective synthetic graft alternatives across trauma and reconstructive care.

How Are Regulatory Evolution, Clinical Evidence, and Cost-Performance Metrics Influencing Competitive Strategy?

Regulatory bodies such as the FDA and EMA are continuously updating guidelines to ensure safety, efficacy, and quality control for artificial bone products. The shift toward evidence-based approvals is prompting manufacturers to invest in long-term clinical trials and post-market surveillance to validate performance in diverse patient populations. Regulatory clarity around biologically enhanced grafts and personalized implants is also streamlining innovation while ensuring clinician and patient confidence in new solutions.

Cost-performance optimization remains a key determinant of adoption. Hospitals and procurement agencies are evaluating artificial bones based on handling ease, integration speed, surgical outcomes, and comparative pricing versus autografts and allografts. Manufacturers that offer modular graft systems, clinician training, and outcome tracking are gaining a competitive edge, especially in price-sensitive healthcare settings. Value-based healthcare models are amplifying the importance of products that reduce revision rates, accelerate recovery, and lower total care costs.

Strategic partnerships among device manufacturers, biotech firms, and research institutions are accelerating the development of next-generation artificial bones. These collaborations are fostering innovation in smart bone implants that incorporate biosensors, drug-delivery functions, or regenerative coatings. With competition intensifying, branding, surgeon loyalty programs, and differentiated clinical support services are becoming central to market positioning across both mature and emerging regions.

What Are the Factors Driving Growth in the Artificial Bones Market?

The artificial bones market is expanding rapidly, driven by the convergence of aging demographics, orthopedic innovation, and demand for safe, scalable alternatives to autologous grafts. As the global burden of bone defects, trauma injuries, and reconstructive needs grows, artificial bones offer a reliable, versatile solution across a wide range of surgical interventions. Their ability to reduce complications, eliminate donor-site morbidity, and shorten recovery times is increasingly aligned with modern surgical and economic priorities.

Product innovation in materials, biologic integration, and patient-specific customization is reshaping competitive dynamics and expanding clinical indications. Regulatory backing, surgeon acceptance, and investment in R&D pipelines are strengthening the commercialization landscape. As healthcare systems seek cost-effective, outcomes-driven orthopedic solutions, artificial bones are emerging as a cornerstone of next-generation musculoskeletal treatment.

Looking ahead, the market’s trajectory will depend on how effectively artificial bone technologies integrate with personalized medicine, regenerative therapies, and digitized surgical workflows. As demand for biologically intelligent and functionally adaptive implants rises, could artificial bones evolve into smart scaffolds that not only replace but actively regenerate and restore human skeletal structures?

SCOPE OF STUDY:

The report analyzes the Artificial Bones market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Material (Ceramics, Composite, Polymer, Hydroxyapatite, Other Materials); Application (Spinal Fusion, Dental, Craniomaxillofacial, Joint Reconstruction, Trauma & Extremities); End-User (Hospitals, Specialty Clinics, Research & Academic Institutes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 37 Featured) -

  • AlloSource
  • Baxter International Inc.
  • Biogennix
  • Biomatlante
  • Bone Support AB
  • Cowellmedi Co., Ltd.
  • Curasan AG
  • DePuy Synthes (Johnson & Johnson)
  • DSM Biomedical
  • Epibone
  • Geistlich Pharma AG
  • Graftys SA
  • Kuros Biosciences AG
  • LifeNet Health
  • Mathys Ltd Bettlach
  • Maxigen Biotech Inc.
  • Medtronic plc
  • NovaBone Products, LLC
  • NuVasive, Inc.
  • Orthofix Medical Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Artificial Bones - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Trauma, Fractures, and Orthopedic Disorders Throws the Spotlight on Artificial Bone Implants
    • Growth in Minimally Invasive and Reconstructive Surgeries Spurs Demand for Biocompatible Bone Substitutes
    • OEM Advancements in 3D Printing and Scaffold Engineering Strengthen Customization of Synthetic Bone Designs
    • Increased Use of Calcium Phosphate and Hydroxyapatite Compounds Enhances Integration With Natural Bone
    • Adoption in Dental Implants and Craniofacial Surgery Expands Scope Beyond Large Orthopedic Reconstructions
    • Surge in Geriatric Population and Osteoporosis Cases Drives Market for Bone Void Fillers
    • Expansion of Bioactive and Growth Factor-Infused Materials Bodes Well for Accelerated Regeneration
    • Use of Artificial Bones in Trauma Management and Military Medicine Enhances Emergency Response Capabilities
    • Growth in Veterinary Orthopedic Procedures Opens Parallel Demand in Animal Healthcare
    • Global Investment in Biomaterials R&D Supports Innovation in Hybrid and Smart Bone Graft Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Bones Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Bones by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Bones by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Ceramics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Ceramics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Composite by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Composite by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Polymer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hydroxyapatite by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Hydroxyapatite by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other Materials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Trauma & Extremities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Trauma & Extremities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Spinal Fusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Spinal Fusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Dental by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Dental by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Craniomaxillofacial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Craniomaxillofacial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Joint Reconstruction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Joint Reconstruction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Research & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Research & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Bones Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 30: USA Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
  • CANADA
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
  • JAPAN
    • Artificial Bones Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
  • CHINA
    • Artificial Bones Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 48: China Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
    • TABLE 52: China Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: China 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
  • EUROPE
    • Artificial Bones Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Artificial Bones by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Artificial Bones by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
    • TABLE 58: Europe Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Europe 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Europe 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
  • FRANCE
    • Artificial Bones Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
    • TABLE 64: France Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: France 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
    • TABLE 66: France Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: France 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
  • GERMANY
    • Artificial Bones Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
    • TABLE 70: Germany Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Germany 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
    • TABLE 72: Germany Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Germany 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
    • TABLE 76: Italy Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Italy 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
    • TABLE 78: Italy Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Italy 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Bones Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
    • TABLE 82: UK Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: UK 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
    • TABLE 84: UK Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: UK 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
    • TABLE 88: Rest of Europe Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of Europe 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
    • TABLE 90: Rest of Europe Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of Europe 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Bones Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
    • TABLE 94: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Asia-Pacific 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
    • TABLE 96: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Asia-Pacific 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
    • TABLE 100: Rest of World Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Rest of World 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
    • TABLE 102: Rest of World Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Rest of World 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030

IV. COMPETITION